Home > PE Ratio > JAGSONPAL PHARMACEUTICALS

JAGSONPAL PHARMACEUTICALS
PE (Price/Earnings) Ratio

The Current P/E Ratio of JAGSONPAL PHARMACEUTICALS is 31.17.

Share Price ₹200.2May 18,2026
Market Cap ₹1,343.0 Cr
Earnings-TTM₹43.1 CrTTM-Standalone Results
Price/Earnings31.17xCalculated as Market Cap/Earnings
Explore Stock Analytics
COMMUNITY POLL
for JAGSONPAL PHARMACEUTICALS
Please provide your vote to see the results

Definition & Calculation of PE (Price/Earnings) ratio of JAGSONPAL PHARMACEUTICALS

Price-to-Earnings ratio, P/E Multiple, or P/E Ratio is an important valuation multiple that is defined as:

P/E = Market Capitalization / Net Income

or, using per-share numbers:

P/E = Stock Price / Earnings Per Share (EPS)

Applying the above formula, P/E ratio of JAGSONPAL PHARMACEUTICALS is calculated as :

Current Market Cap [ ₹1,343.0 Cr] as on May 18,2026

(/) Earnings [ ₹43.1 Cr] based on TTM-Standalone Results

(=) P/E Ratio [ 31.17x ]

P/E Ratio indicates the multiple of earnings investors are willing to pay to own one share of the company.

Thus, for JAGSONPAL PHARMACEUTICALS , the investors are currently willing to pay 31.17 times earnings to own 1 share of the company.

PE Multiples are the most widely used valuation multiple in practice.

Since P/E ratio uses Net Income in the calculation, P/E multiples are not always reliable for valuing companies with negative earnings.

In such cases, you may consider using Price to Book ratio or Price to Sales ratio of JAGSONPAL PHARMACEUTICALS !

P/E ratios, also, would not adjust for differences in the capital structure between companies.

The chart below summarizes the trend in P/E Ratio of JAGSONPAL PHARMACEUTICALS over the last five years.

Historical PE (Price/Earnings) ratio chart of JAGSONPAL PHARMACEUTICALS


PE Ratio Performance Analysis for JAGSONPAL PHARMACEUTICALS

- JAGSONPAL PHARMACEUTICALS 's latest p/e ratio is 31.17x.

- JAGSONPAL PHARMACEUTICALS 's p/e ratio for fiscal years ending Mar2025 to Mar2021 averaged 24.66x.

- JAGSONPAL PHARMACEUTICALS 's operated at median p/e ratio of 25.9x from fiscal years ending March 2018 to 2022.

- Looking back at the last 5 fiscal years, JAGSONPAL PHARMACEUTICALS 's p/e ratio peaked in Mar2022 at 43.57x.

- JAGSONPAL PHARMACEUTICALS 's p/e ratio hit its five-year low in Mar2021 of 12.22x.


How does JAGSONPAL PHARMACEUTICALS 's P/E Ratio benchmark against top 10 peers in Pharmaceuticals & Drugs Industry?

Peer Comparison (Pharmaceuticals & Drugs Industry)Earnings-TTM (Cr)PE RatioMarket Cap
JAGSONPAL PHARMACEUTICALS 43.0831.171,343.0
SUN PHARMACEUTICAL INDUSTRIES LTD11,001.4041.55457,121.0
DIVIS LABORATORIES LTD2,479.0073.17181,396.0
TORRENT PHARMACEUTICALS LTD2,272.0065.46148,730.0
CIPLA LTD3,869.7929.78115,241.0
DR REDDYS LABORATORIES LTD4,144.2026.81111,126.0
MANKIND PHARMA LTD1,796.6557.36103,056.0
LUPIN LTD5,355.4719.23103,011.0
ZYDUS LIFESCIENCES LTD4,933.9020.2199,737.9
AUROBINDO PHARMA LTD3,513.2024.5986,401.6
LAURUS LABS LTD889.8580.5271,647.1

Pharmaceuticals & Drugs Industry Benchmark (Top 10) PE Analysis vs JAGSONPAL PHARMACEUTICALS 's P/E Ratio

Top 10 Industry PeersPE Ratio
Min industry PE 19.23x
Max industry PE 80.52x
Median industry PE 31.17x
Average industry PE 42.72x



You may also like the below Video Courses